Uscom Limited (ASX:UCM)

Market Cap	3.51M
Revenue (ttm)	3.63M
Net Income (ttm)	-2.36M
Shares Out	250.48M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,000
Average Volume	92,633
Open	0.0140
Previous Close	0.0140
Day's Range	0.0140 - 0.0140
52-Week Range	0.0110 - 0.0450
Beta	-1.32
RSI	24.89
Earnings Date	Aug 15, 2025

About Uscom

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm. The company also provides the SpiroSonic Ultrasonic spirometer, a pulmonary function testing device that ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 35
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: UCM

Financial Performance

In 2024, Uscom's revenue was 3.73 million, an increase of 39.89% compared to the previous year's 2.66 million. Losses were -2.07 million, -19.92% less than in 2023.